(19)
(11) EP 0 952 216 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.10.2005 Bulletin 2005/42

(45) Mention of the grant of the patent:
17.08.2005 Bulletin 2005/33

(21) Application number: 99105019.6

(22) Date of filing: 12.10.1995
(51) International Patent Classification (IPC)7C12N 15/10, C12Q 1/68

(54)

Solid phase supports with PNA and amidate tag compliments

Mit PNA- und Amidat-Etiketten bestückte Festphasenträger

Supports en phase solide avec un tag d'ANP et d'amidate


(84) Designated Contracting States:
BE CH DE DK FR GB IT LI NL SE

(30) Priority: 13.10.1994 US 322348
19.12.1994 US 359295

(43) Date of publication of application:
27.10.1999 Bulletin 1999/43

(62) Application number of the earlier application in accordance with Art. 76 EPC:
95937322.6 / 0786014

(73) Proprietor: Solexa, Inc
Hayward CA 94545 (US)

(72) Inventor:
  • Brenner, Sydney
    Cambridge CB2 3PJ (GB)

(74) Representative: Vossius & Partner 
Siebertstrasse 4
81675 München
81675 München (DE)


(56) References cited: : 
EP-A- 0 303 459
WO-A-92/03461
WO-A-93/06121
WO-A-93/17126
WO-A-93/22684
WO-A-95/23163
WO-A-90/03382
WO-A-92/10588
WO-A-93/13220
WO-A-93/22680
WO-A-94/08051
   
  • S. GRAYAZNOV AND J.-K. CHEN: "Oligodeoriribonucleotide N3'-5'P phosphoramidates: Synthesis and Hybridization properties" J. AM. CHEM. SOCIETY, vol. 116, 1994, pages 3143-3144, XP002123664 AMERICAN CHEMICAL SOCIETY, US
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).